Protection has always been expensive for those in high risk occupations, but is it fair that consumers may compromise on product quality? Paul Wood examines the case for IP
Many advisers view lead generation firms with suspicion, but is this justified? Justin Rees explains how purchasing consumer information in the form of leads can help new business blossom
Being off work for extended periods impacts on a person's wellbeing as well as their income. Chris McFarlane notes advisers could make more of rehabilitation services as a sales tool
Living with rheumatoid arthritis can make normal daily activities incredibly challenging. Scott Robertson talks symptoms, treatment and underwriting implications
The protection industry has demonstrated significant technological advancements over recent years. Ed Stuart-Brown examines the effect this had on business processing and efficiency
Everyone agrees an improvement in the nation's health would take the strain off healthcare provision. Fiona Harris asks where the balance of responsibility lies
The FSA has attracted mixed opinion surrounding its principles-based regulation with providers and advisers disagreeing over whether they need to be on tighter reins. Lucy Quinton explains
Coping with the loss of a loved-one is difficult enough without having to deal with financial burdens that remain. Peter Carvill explores which types of lifestage cover are most appropriate in the event of death
As the UK turns into a nation of singletons, Iain Mallon explains why advisers need to rethink how they sell protection to address this new market
This kidney disease can affect the young as well as the elderly. With no treatment for the condition, Vanessa Leyland explains how its development can be slowed through maintaining a healthy blood pressure